Thyroid Function Before, During, and After COVID-19

Bernard Khoo(University College London), Waljit S. Dhillo(Imperial College London), Karim Meeran(Imperial College Healthcare NHS Trust), Layla Thurston(Imperial College Healthcare NHS Trust), Edouard Mills(Imperial College Healthcare NHS Trust), Alexander Comninos(National Health Service), Maria Phylactou(Imperial College London), Tricia Tan(Imperial College London), Ali Abbara(National Health Service), Bijal Patel(National Health Service), Emma Alexander(Imperial College London), Pei Chia Eng(Imperial College London), Manish Modi(Imperial College London), Sophie Clarke(Imperial College London)
The Journal of Clinical Endocrinology & Metabolism
November 12, 2020
10.1210/clinem/dgaa830
Cited by 220

Related Papers

Association Between Use of Sodium-Glucose Cotransporter 2 Inhibitors, Glucagon-like Peptide 1 Agonists, and Dipeptidyl Peptidase 4 Inhibitors With All-Cause Mortality in Patients With Type 2 Diabetes
|JAMA|2018|406
Association between high serum total cortisol concentrations and mortality from COVID-19
|The Lancet Diabetes & Endocrinology|2020|260
Male infertility due to testicular disorders
|The Journal of Clinical Endocrinology & Metabolism|2020|246
Cause of Death and Predictors of All‐Cause Mortality in Anticoagulated Patients With Nonvalvular Atrial Fibrillation: Data From ROCKET AF
|Journal of the American Heart Association|2016|199
Neurokinin B Administration Induces Hot Flushes in Women
|Scientific Reports|2015|161